Literature DB >> 19372340

Postoperative intensive care unit drug fever caused by dexmedetomidine.

Tadashi Okabe1, Shinhiro Takeda, Shinji Akada, Takashi Hongo, Atsuhiro Sakamoto.   

Abstract

Dexmedetomidine hydrochloride is a potent, highly selective alpha-2 adrenergic receptor agonist, broadly used as a sedative drug in intensive care units. We describe the case of a 59-yr-old patient who experienced drug fever caused by dexmedetomidine hydrochloride. The patient was transferred to the intensive care unit with an abdominal aortic aneurysm rupture. After initiation of sedation with dexmedetomidine hydrochloride, he developed pyrexia of more than 39 degrees C. This symptom improved rapidly 7 h after stopping dexmedetomidine hydrochloride. Other possible causes (such as infection) were sequentially eliminated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372340     DOI: 10.1213/ane.0b013e31819f1985

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Dexmedetomidine-associated fever in the intensive care unit.

Authors:  Andrew C Faust; Shelby E Sutton
Journal:  Ther Adv Drug Saf       Date:  2015-12

2.  Dexmedetomidine-Associated Fever in a Critically Ill Obese Child.

Authors:  R Zachary Thompson; Lori McDonald; Keegan Ziemba; Joseph D Tobias; Claire A Stewart
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Nov-Dec

3.  Drug fever caused by propofol in the intensive care unit.

Authors:  Tomoaki Yatabe; Koichi Yamashita; Masataka Yokoyama
Journal:  J Anesth       Date:  2015-03-24       Impact factor: 2.078

4.  Dexmedetomidine-Induced Fever in a 66-Year-Old Male With Pneumonia and Pleural Effusion.

Authors:  Ayesha Imtiaz; Ankita Prasad; Andrea Marin; Lwoodsky Charles; Varun Vankeshwaram; Pramil Cheriyath
Journal:  Cureus       Date:  2022-07-03

5.  Evaluation of dexmedetomidine anesthesia-related temperature changes: preliminary retrospective observational study.

Authors:  Felipe Aparecido Ferreira da Cruz; Luiz Fernando Dos Reis Falcão; José Luiz Gomes do Amaral; Helga Cristina Almeida da Silva
Journal:  Braz J Anesthesiol       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.